Search

Your search keyword '"Falzon, Mary"' showing total 158 results

Search Constraints

Start Over You searched for: Author "Falzon, Mary" Remove constraint Author: "Falzon, Mary" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
158 results on '"Falzon, Mary"'

Search Results

1. Author Correction: The evolution of lung cancer and impact of subclonal selection in TRACERx

2. The evolution of non-small cell lung cancer metastases in TRACERx

3. The evolution of lung cancer and impact of subclonal selection in TRACERx

4. Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer : TARGIT-A randomised clinical trial

5. New clinical and biological insights from the international TARGIT-A randomised trial of targeted intraoperative radiotherapy during lumpectomy for breast cancer

6. The QuinteT Recruitment Intervention supported five randomized trials to recruit to target: a mixed-methods evaluation

7. HER2 testing

8. An observational study showed that explaining randomization using gambling-related metaphors and computer-agency descriptions impeded randomized clinical trial recruitment

9. Breast Cancer

10. Data from Late-Stage Metastatic Melanoma Emerges through a Diversity of Evolutionary Pathways

11. Supplementary Tables S1-S8 from Late-Stage Metastatic Melanoma Emerges through a Diversity of Evolutionary Pathways

12. Supplementary Figures S1-S25 from Late-Stage Metastatic Melanoma Emerges through a Diversity of Evolutionary Pathways

13. Table S2 from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer

14. Data from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer

15. Supplementary Data from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer

16. Body composition and lung cancer-associated cachexia in TRACERx

17. The evolution of lung cancer and impact of subclonal selection in TRACERx

18. Evolutionary characterization of lung adenocarcinoma morphology in TRACERx

20. Late-stage metastatic melanoma emerges through a diversity of evolutionary pathways

21. Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution

23. Abstract PR002: Advanced melanoma exhibits a diversity of evolutionary routes to lethality

24. Abstract A012: Advanced melanoma exhibits a diversity of evolutionary routes to lethality

26. Allele-informed copy number evaluation of plasma DNA samples from metastatic prostate cancer patients: the PCF_SELECT consortium assay

27. Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma

29. Research in progress—LungSEARCH: a randomised controlled trial of surveillance for the early detection of lung cancer in a high-risk group

31. Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma

32. Corrigendum: Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution

34. Determinants of anti-PD1 response and resistance in clear cell renal cell carcinoma

35. Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer

36. Effect of Delayed Targeted Intraoperative Radiotherapy vs Whole-Breast Radiotherapy on Local Recurrence and Survival

37. Representative Sequencing: Unbiased Sampling of Solid Tumor Tissue

38. Effect of Delayed Targeted Intraoperative Radiotherapy vs Whole-Breast Radiotherapy on Local Recurrence and Survival

39. The QuinteT Recruitment Intervention supported five randomized trials to recruit to target: a mixed-methods evaluation

40. Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal

41. Fc effector function contributes to the activity of human anti-CTLA-4 antibodies

42. Immune surveillance in clinical regression of pre-invasive squamous cell lung cancer

43. Sequential screening for lung cancer in a high-risk group: randomised controlled trial

44. The QuinteT Recruitment Intervention supported five randomized trials to recruit to target: a mixed-methods evaluation

45. Deciphering the genomic, epigenomic, and transcriptomic landscapes of pre-invasive lung cancer lesions

46. Retrospective response analysis of BAP1 expression to predict the clinical activity of systemic cytotoxic chemotherapy in mesothelioma

47. Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal

48. Fc-Optimized Anti-CD25 depletes tumor-infiltrating regulatory T Cells and synergizes with PD-1 Blockade to eradicate established tumors

49. An observational study showed that explaining randomization using gambling-related metaphors and computer-agency descriptions impeded randomized clinical trial recruitment

50. Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal

Catalog

Books, media, physical & digital resources